Showing results (531-540 of 630) with videos related to

Sort By:
Pageof 63
Journal of the American Academy of Dermatology|March 13, 2025
Long-term safety and efficacy of delgocitinib cream for up to 52 weeks in adults with Chronic Hand Eczema: Results of the phase 3 open-label extension DELTA 3 trial following the DELTA 1 and 2 trialsMelinda Gooderham, Sonja Molin, Robert Bissonnette, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|May 10, 2021
North American Contact Dermatitis Group Patch Test Results: 2017-2018Joel G DeKoven, Jonathan I Silverberg, Erin M Warshaw, et al.
Dermatology and Therapy|June 2, 2025
Rapid Itch Improvement and Skin Clearance with Upadacitinib Versus Placebo (Measure Up 1 and Measure Up 2) and Versus Dupilumab (Heads Up): Results from Three Phase 3 Clinical Trials in Patients with Moderate-to-Severe Atopic DermatitisEric L Simpson, Jonathan I Silverberg, Vimal H Prajapati, et al.
Journal of Drugs in Dermatology : JDD|August 20, 2019
Efficacy of Dupilumab in Different Racial Subgroups of Adults With Moderate-to-Severe Atopic Dermatitis in Three Randomized, Placebo-Controlled Phase 3 TrialsAndrew F. Alexis, Marta Rendon, Jonathan I. Silverberg, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 19, 2023
Abrocitinib efficacy and safety in patients with moderate-to-severe atopic dermatitis: Results from phase 3 studies, including the long-term extension JADE EXTEND studyKristian Reich, Jonathan I Silverberg, Kim A Papp, et al.
American Journal of Clinical Dermatology|May 9, 2019
Infections in Dupilumab Clinical Trials in Atopic Dermatitis: A Comprehensive Pooled AnalysisLawrence F Eichenfield, Thomas Bieber, Lisa A Beck, et al.
Contact Dermatitis|April 12, 2021
Patch testing with sodium disulfite: North American Contact Dermatitis Group experience, 2017 to 2018Erin M Warshaw, Michele Buonomo, Joel G DeKoven, et al.
Contact Dermatitis|December 11, 2022
Prevalence and trend of allergen sensitization in patients with cheilitis referred for patch testing, North American Contact Dermatitis Group data, 2001-2018Jonathan I Silverberg, Manotri Chaubal, Erin M Warshaw, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|December 4, 2020
Positive Patch Test Reactions to Carba Mix and Thiuram Mix: The North American Contact Dermatitis Group Experience (1994-2016)Erin M Warshaw, Rachit Gupta, Jonathan I Silverberg, et al.
JAMA Dermatology|March 13, 2024
Expert Recommendations on Use of Topical Therapeutics for Vitiligo in Pediatric, Adolescent, and Young Adult PatientsYael Renert-Yuval, Khaled Ezzedine, Pearl Grimes, et al.
Pageof 63